Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 14, 2018

SELL
$20.99 - $23.89 $3.29 Million - $3.74 Million
-156,733 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$20.07 - $21.89 $3.15 Million - $3.43 Million
156,733
156,733 $3.43 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6.03B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Btg Pactual Global Asset Management LTD Portfolio

Follow Btg Pactual Global Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.